11 NOVEMBER 2026, WEDNESDAY
| Time | 09:00 – 17:00 (GMT+8) | |||
| Venue | Grand Hyatt Singapore, Residence 5, Level 3 | |||
| Format | Interactive, case-based multidisciplinary workshop focused on precision lung cancer care, integrating molecular tumour board discussions, real-world case simulations, and live audience polling. | |||
| Introduction | This workshop focuses on the practical application of molecular profiling in lung cancer, including NGS, liquid biopsy, and minimal residual disease (MRD). Emphasis is placed on translating biomarker data into real-world clinical decision-making across early-stage and advanced disease settings. | |||
| Objectives | – Apply NGS and molecular profiling in lung cancer management
– Interpret ctDNA and MRD results in clinical practice – Integrate biomarker data into treatment decisions – Manage early and advanced NSCLC using precision oncology approaches – Conduct multidisciplinary tumour board (MTB)–style decision-making in clinical scenarios – Discuss real-world challenges in implementing molecular diagnostics in routine practice – Evaluate emerging roles of perioperative and adjuvant biomarker-guided therapies |
|||
| Target Participants | Medical oncologists, thoracic surgeons, pulmonologists, pathologists, radiation oncologists, trainees, and allied health professionals. | |||
| Participants Number | 50 pax | |||
| Lead Faculty | Aaron Tan | |||
| Faculty | Jens Samol
Ramaswamy Govindan Tim Benepal |
|||
| Cost per pax | SGD 250 / USD 195 | |||
| Registration | This Workshop is available as an add-on to the Main Congress. Click here to register. | |||
| Time | 09:00 – 16:00 (GMT+8) | |||
| Venue | Grand Hyatt Singapore, Residence 6, Level 3 | |||
| Format | Rotating hands-on stations with focused short didactic sessions and practical demonstrations | |||
| Introduction | This hands-on workshop is designed to strengthen both the technical execution and clinical reasoning required for advanced bronchoscopy and interventional pulmonology. Each station combines short expert demonstrations with deliberate practice, troubleshooting, and discussion of indications, safety checks, and complication management | |||
| Objectives |
– Develop a structured approach to procedure planning, including indication, airway anatomy, lesion or nodal target, device selection, and rescue strategy. – Improve hands-on familiarity with convex-probe EBUS bronchoscopes, R-EBUS probes, guide sheaths, biopsy tools, cryoprobes, ablative devices, rigid bronchoscopes, and airway stents. – Practice stepwise technical execution with attention to ergonomics, team communication, equipment readiness, and procedural flow. – Recognise pitfalls early and apply practical strategies for bleeding, airway obstruction, pneumothorax risk, device malposition, and loss of target access. |
|||
| Target Participants | Respiratory physicians, interventional pulmonologists, thoracic surgeons, respiratory and thoracic fellows and trainees, intensivists with an interest in advanced bronchoscopy, bronchoscopy nurses, and allied healthcare professionals involved in bronchoscopy services. | |||
| Participants Number | 50 pax | |||
| Lead Faculty | Melvin Tay C.K. | |||
| Faculty |
Brian Chua L W Carrie Leong Clare Fong Eric D. Tenda Eugene Gan Hari Kishan Gonuguntla Khai Lip Ng Kho Sze Shyang Lee Pyng Phan Nguyen Ronald Fajardo Sean Loh Thitiwat S. Wang Hai |
|||
| Cost per pax | SGD 250 / USD 195 | |||
| Registration | This Workshop is available as an add-on to the Main Congress. Click here to register. | |||
Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety, and performance of our single-use endoscopy, anaesthesia, and patient monitoring solutions.
We are driven by our strong purpose: Together, we rethink solutions to save lives and improve patient care.
Working with Sustainability: The Ambu Way
For more information, please visit www.ambu.com
GE HealthCare Technologies Inc. is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine to help clinicians deliver more personalised, precise patient care. This is complemented by our broad service capabilities and dedication to quality and integrity with a strong operational culture, supported by our lean business system, Heartbeat.
For more information, please visit www.gehealthcare.com/en-sg
At Olympus, our Purpose is to make people’s lives healthier, safer, and more fulfilling. For more than 100 years, we have partnered with healthcare professionals to advance medical technology and deliver solutions that support early detection, accurate diagnosis, and minimally invasive treatment.
Our commitment to improving patient care is reflected in our continued investment in clinically advanced, precision technologies and services. In respiratory care, we are passionate about supporting healthcare professionals in the diagnosis and management of lung disease, particularly lung cancer, where early and accurate diagnosis can make a meaningful difference to patient outcomes.
Through our comprehensive portfolio of minimally invasive respiratory and lung cancer solutions, Olympus strives to help clinicians visualize, diagnose, and treat disease with greater confidence. By combining clinical expertise with innovative technology, we aim to elevate the standard of care and contribute to better outcomes for patients today and into the future.
For more information, please visit www.olympus-global.com/apac
